Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1993-06-22
1997-07-08
Furman, Keith C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4352533, 4353201, 435325, 435358, 435365, 435356, 435367, 435366, 435354, 435369, 435364, 435350, 536 235, 536 2431, 536 2433, C12N 510, C12N 512
Patent
active
056460082
ABSTRACT:
The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.
REFERENCES:
patent: 5082774 (1992-01-01), Heinrich
Allsopp et al., The Proto-Oncogene bcl-2 Can Selectively Rescue Neurotrophic Factor-Dependent Neurons from Apoptosis, Cell, 73:295, 1993.
Bakhshi et al., Cloning the Chromosomal Breakpoint of t(14;18) Human Lymphomas: Clustering around J.sub.H on Chromosome 14 and near a Transcriptional Unit on 18, Cell, 41:899, 1985.
Borzill et al., Bcl-2 Confers Growth and Survival Advantage to Interleukin 7-dependent Early Pre-B Cells Which Become Factor Independent by a Multistep Process in Culture, Oncogene, 7:869, 1992.
Cazals-Hatem et al., Molecular Cloning and DNA Sequence Analysis of cDNA Encoding Chicken Homologue of the Bcl-2 Oncoprotein, Biochim. Biophys. Acta, 1132:109, 1992.
Chen-Levy, Z. and Cleary, M.L., Membrane Topology of the Bcl-2 Proto-oncogenic Protein Demonstrated in Vitro, J. Biol. Chem., 265:4929, 1990.
Chen-Levy et al., The bcl-2 Candidate Proto-Oncogene Product Is a 24-Kilodalton Integral-Membrane Protein Highly Expressed in Lymphoid Cell Lines and Lymphomas Carrying the t(14;18) Translocation, Mol. Cell. Biol., 9:701, 1989.
Cleary et al., Cloning and Structural Analysis of cDNAs for bcl-2 and a Hybrid bcl-2/Immunoglobulin Transcript Resulting from the t(14;18) Translation, Cell, 47:19, 1986.
Eguchi et al., Isolation and Characterization of the Chicken bcl-2 Gene: Expression in a Variety of Tissues Including Lymphoid and Neuronal Organs in Adult and Embryo, Nucl. Acids. Res., 20:4187, 1992.
Garcia et al., Prevention of Programmed Cell Death of Sympathetic Neurons by the bcl-2 Prot-Oncogene, Science, 258:302, 1992.
Graninger et al., Expression of Bcl-2 and Bcl-2-lg Fusion Transcripts in Normal and Neoplastic Cells, J. Clin. Invest., 80:1512, 1987.
Hockenbery et al., Bcl-2 is an Inner Mitochondrial Membrane Protein That Blocks Programmed Cell Death, Nature, 348:334, 1990.
Kawabe, Y. and Ochi, A. Programmed Cell Death and Extrathymic Reduction of V.beta.8.sup.+ Cells in Mice Tolerant to Staphylococcus aureus Enterotoxin B, Nature, 349:245, 1991.
Korsmeyer, S., Chromosomal Translocations in Lymphoid Malignancies Reveal Novel Proto-Oncogenes, Annu. Rev. Immunol., 10:785-807, 1992.
McCarthy et al., Apoptosis in the development of the immune system: Growth factors, clonal selection and bcl-2, Cancer Metastasis Reviews, 11:157-178, 1992.
Nunez et al., Deregulated Bcl-2 Gene Expression Selectively Prolongs Survival of Growth Factor-Deprived Hemopoietic Cell Lines, J. Immunol., 144:3602, 1990.
Raff, M.C., Social controls on cell survival and cell death, Nature, 356:397-400, 1992.
Reed et al., Regulation of bcl-2 Proto-Oncogene Expression During Normal Human Lymphocyte Proliferation, Science, 236:1295, 1987.
Sentman et al., Bcl-2 Inhibits Multiple Forms of Apoptosis but Not Negative Selection in Thymocytes, Cell, 67:879, 1991.
Siegel et al., Inhibition of Thymocyte Apoptosis and Negative and Antigenic Selection in bcl-2 Transgenic Mice, Proc. Natl. Acad. Sci. USA, 89:7003, 1992.
Strasser et al., Bcl-2 Transgene Inhibits T Cell Death and Perturba Thymic Self-Censorship, Cell, 67:889, 1991.
Strasser et al., Enforced BCL2 Expression in B-lymphoid Cells Prolongs Antibody Responses and Elicits Autoimmune Disease, Proc. natl. Acad. Sci. USA, 88:8661, 1991.
Tsujimoto, Y. and Croce, C.M., Analysis of the Structure, Transcripts, and Protein Products bcl-2, the Gene Involved in Human Follicular Lymphoma, Proc. Natl. Acad. Sci. USA, 83:5214, 1986.
Vaux et al., Bcl-2 Gene Promotes Haemopoietic Cell Survival and Cooperates with c-myc to Immortalize Pre-B Cells, Nature, 335:440, 1988.
Webb et al., Extrathymic Tolerance of Mature T Cells: Clonal Elimination as a Consequence of Immunity, Cell, 63:1249, 1990.
Day, R.A. 1983. How to Write and Publish a Scientific Paper, iSi Press, Philadelphia, PA, pp. 15-19.
Boise et al. Aug. 1993, Cell 74:597-608.
Boise Lawrence H.
Nunez Gabriel
Thompson Craig B.
Furman Keith C.
The Regent of the University of Michigan
LandOfFree
Vertebrate apoptosis gene: compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vertebrate apoptosis gene: compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vertebrate apoptosis gene: compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2408289